Outcomes with Molecularly Targeted Agents as Salvage Therapy Following Frontline Venetoclax + Hypomethylating Agent in Adults with Acute Myeloid Leukemia: A Multicenter Retrospective Analysis

MLA

Vishesh Khanna, et al. “Outcomes with Molecularly Targeted Agents as Salvage Therapy Following Frontline Venetoclax + Hypomethylating Agent in Adults with Acute Myeloid Leukemia: A Multicenter Retrospective Analysis.” Leukemia Research, May 2023, p. 107331. EBSCOhost, https://doi.org/10.1016/j.leukres.2023.107331.

APA

Vishesh Khanna, Tali Azenkot, Selina (Qiuying) Liu, Jason Gilbert, Edna Cheung, Kimberly Lau, Daniel A Pollyea, Elie Traer, Brian A Jonas, Tian Y Zhang, & Gabriel N Mannis. (2023). Outcomes with Molecularly Targeted Agents as Salvage Therapy Following Frontline Venetoclax + Hypomethylating Agent in Adults with Acute Myeloid Leukemia: A Multicenter Retrospective Analysis. Leukemia Research, 107331. https://doi.org/10.1016/j.leukres.2023.107331

Chicago

Vishesh Khanna, Tali Azenkot, Selina (Qiuying) Liu, Jason Gilbert, Edna Cheung, Kimberly Lau, Daniel A Pollyea, et al. 2023. “Outcomes with Molecularly Targeted Agents as Salvage Therapy Following Frontline Venetoclax + Hypomethylating Agent in Adults with Acute Myeloid Leukemia: A Multicenter Retrospective Analysis.” Leukemia Research, May, 107331. doi:10.1016/j.leukres.2023.107331.